WHAT THE STUDY ACTUALLY SAYS

App-based coaching through pregnancy did not lower maternal weight in a large trial

The Bump2Baby trial coached 865 women at raised risk of gestational diabetes from early pregnancy to a year after birth. Their body mass index at 12 months was no different from women given usual care.

A smartphone coaching programme that supported women from early pregnancy through a full year after birth did not reduce their body mass index at 12 months, according to a four-country randomised controlled trial published on 12 November in The Lancet Digital Health [s1]. The programme was aimed at women already at raised risk of gestational diabetes, and the trial was large and well designed — which makes the flat result informative rather than merely disappointing.

Being overweight or obese in pregnancy raises the risk of gestational diabetes and other adverse pregnancy outcomes [s1]. Digital health tools are attractive because they are scalable and can be personalised, but the authors note that evidence for programmes spanning both pregnancy and the postpartum year has been scarce [s1]. Bump2Baby and Me was built to test exactly that extended window.

What the trial did

The study was a multicentre, randomised controlled trial run in Australia, Ireland, Spain and the United Kingdom [s1]. It enrolled pregnant women aged 18 or older, between 12 and 24 weeks of gestation, who scored at increased risk on the Monash gestational-diabetes risk tool — a score of at least 3, built from maternal age, body mass index, ethnicity, family history of diabetes and any past history of gestational diabetes [s1].

Participants were randomly assigned one to one, using computer-generated block randomisation stratified by site, to one of two groups [s1]. The intervention group received personalised mobile-health coaching delivered through a smartphone — both synchronous and asynchronous support — from pregnancy through to 12 months postpartum, on top of usual maternity care. The control group received usual maternity care alone. Gestational-diabetes screening and management continued unchanged in both groups, and both groups were given Bluetooth-enabled scales [s1].

Participants and their health coaches could not be masked to which group they were in, but the clinical staff delivering usual care, the laboratory staff and the trial statisticians were [s1]. The pre-specified primary outcome was the between-group difference in mean body mass index at 12 months postpartum [s1].

What it found

Between 9 February 2021 and 22 October 2023, researchers screened 4,386 women, excluded 3,521, and randomly assigned 865 — 437 to the coaching intervention and 428 to the control group [s1]. The mean age of participants was 35.2 years, and most were White, 588 of 804 (73%) [s1].

On the primary outcome, the two groups were essentially identical. The mean change in body mass index did not differ: −0.04 kg/m² in the intervention group against 0.04 kg/m² in the control group [s1]. In other words, a year of personalised coaching produced no measurable advantage in weight over usual care.

Safety data were reassuring in both directions. Adverse events were recorded in 18% of the intervention group (79 of 437) and 25% of controls (106 of 428); serious adverse events occurred in 6% (28 of 437) and 9% (40 of 428) respectively [s1]. None of the adverse or serious adverse events were judged to be related to the intervention [s1].

How to read it

This is a null result from a strong trial, and that combination matters. The study ran across four countries, randomised more than 800 women, kept usual care identical between groups, and masked the staff who assessed outcomes — the design features that make a flat finding trustworthy rather than a sign the programme was never given a fair test [s1]. Within those terms, the conclusion is clean: an extended, personalised mobile-coaching programme did not move the weight needle at one year.

There are limits worth stating. Weight was the primary target, but it is only one of the outcomes that matter after a high-risk pregnancy, and the authors themselves suggest that mobile interventions for at-risk women might do better by addressing a broader range of maternal health outcomes rather than weight alone [s1]. The participants were also predominantly White, which constrains how far the result generalises. And a null on BMI does not rule out benefits the trial was not built primarily to measure.

What to watch

The useful reading is that convenience and personalisation are not, on their own, enough: a well-built app delivered over 18 months did not outperform standard maternity care on maternal weight [s1]. The open questions are whether digital support helps with outcomes other than weight — blood-sugar control, mental health, infant feeding — and whether a programme designed around those targets, in a more diverse population, would fare differently. For context, see our coverage of gestational diabetes and of digital health tools in pregnancy.

This article describes a single trial. It is not medical advice, and decisions about care in pregnancy belong with a woman's own clinicians.

Sources

  1. Personalised mobile health coaching from early pregnancy to 12-months postpartum for females at risk of gestational diabetes (Bump2Baby and Me): a multicentre, randomised controlled trial — The Lancet Digital Health , November 12, 2026

More on

Related coverage